CONCLUSION
Currently, the Shanbally plant construction is more than 60% complete and the commissioning and qualification activity is
just starting. Project team members who were formerly involved with the project design phase have transitioned to commissioning
activities. Recently hired Shanbally plant colleagues will participate in equipment commissioning activities as part of their
education and development program.
Other teams are developing plant manufacturing and quality systems in preparation for plant start up, with engineering batches
planned for 2009. There is a detailed operation readiness plan in place and we are currently 30% complete in this area. The
laboratories will come online in March 2009, and will be ready to support testing of the initial production batches.
As Shanbally's finishing touches come together and the plant nears completion, the hard work of hundreds of people, inside
and outside the company, brings Pfizer another step closer to its objective.
Desmond Fitzgerald is the project leader of the Shanbally project and Ken Bradley is the site leader at the Shanbally plant, both of Pfizer Inc, Shanbally, Ireland, +353 21 500 7947, bradlk@pfizer.com
REFERENCES
1. Wagenigen University [homepage on the Internet]. Wagenigen, the Netherlands: Innovation in Biopharmaceutical Process Development
and Manufacturing; 2006 [cited 2009 Jan]. Available from: http://www.bionovations.org/.
|
